Clinical Trials Browser

Phase 2 × Melanoma × olaparib × Clear all

NCT05482074 2024-01-19

Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2

Phase 2 Withdrawn

Uveal Melanoma, Melanoma

NCT04633902 2022-12-06

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

Phase 2 Unknown

Melanoma